Clinical Trial Update: Immunogenicity Study of Insulin Glargine Ezelin vs Lantus in Type 2 Diabetes Mellitus Patients [Phase 2]

View source ↗

Summary

Phase 2 immunogenicity study comparing insulin glargine Ezelin to Lantus in patients with type 2 diabetes mellitus completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin glargine Ezelin (insulin glargine)
• Lantus (insulin glargine)

Snippet

Sponsor: Indonesia University | Conditions: Diabetes Mellitus | Phase 2 | Status: COMPLETED